Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Jim Bishop who wrote (8785)	9/2/1999 1:56:00 AM
From: scouser	Read Replies (1) \| Respond to of 150070

ONIN on the LIST, seems ready to spike, now @ $4.

To: Jim Bishop who wrote (8785)	9/2/1999 7:40:00 PM
From: Roger Greene	Read Replies (1) \| Respond to of 150070

CRSC follow up--trading below cash and no debt. Thank you for your thoughtful message. With CRSC trading at less than half the value of cash and marketable securities, there have to be some negatives. I think the primary one is that although revenues have increased in the past few quarters, the company does not expect the same increase this quarter. Another loss can be expected. At the same time, the Company indicates that they are taking steps to reduce overhead. After cutting costs, they are looking to break even next year. Even if they don't, the burn rate is low enough to keep them financially sound for a while. On the litigation front, I view the fact that they obtained insurance coverage as a positive, because it reduces financial exposure. I track a number of stocks that trade at or near cash value, but this one really stands out on a value basis. If nothing else, a biotech company that has testing needs could buy them for cash value, and you would still double your money. Right now, I think the biggest downside is the lack of a catalyst to draw interest. Other cash rich companies that are starting to move include BITS and AMLJ, and I would appreciate any thoughts you have about them.